Systematic review and meta-analysis of selected toxicities of approved ALK inhibitors in metastatic non-small cell lung cancer

INTRODUCTION: Anaplastic lymphoma kinase (ALK) inhibitors are the mainstay treatment for patients with non-small cell lung carcinoma (NSCLC) harboring a rearrangement of the ALK gene or the ROS1 oncogenes. With the recent publication of pivotal trials leading to the approval of these compounds in di...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Oncotarget
Main Authors: Costa, Rubens Barros, Costa, Ricardo L.B., Talamantes, Sarah M., Kaplan, Jason B., Bhave, Manali A., Rademaker, Alfred, Miller, Corinne, Carneiro, Benedito A., Mahalingam, Devalingam, Chae, Young Kwang
Format: Artigo
Sprog:Inglês
Udgivet: Impact Journals LLC 2018
Fag:
Meta-Analysis
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5955140/
https://ncbi.nlm.nih.gov/pubmed/29774128
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.25154
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker